Doug Brunk
![1]()
News
Simple bedside tool effectively detected sepsis in the ED
May 30, 2018
An innovative measurement was successful in detecting sepsis.
![1]()
News
In-hospital mortality predictors eyed in pneumonia patient subset
May 22, 2018
About one in four intubated or mechanically ventilated patients with gram-negative pneumonia die during hospitalization, results from a large retrospective cohort study found.
![1]()
News
Which infants with invasive bacterial infections are at risk for adverse outcomes?
May 16, 2018
TORONTO - Adverse outcomes are associated with prematurity, ill appearance, and bacterial meningitis.
![1]()
News
Multiple analgesia options for kids with acute pain
May 14, 2018
TORONTO – When analgesia is indicated, clinicians can choose from a variety of agents in the postcodeine era.
![1]()
News
Does warfarin cause acute kidney injury?
May 2, 2018
SAN DIEGO – Consider increased monitoring of renal function in certain patients.
![1]()
News
The ‘holy grail’ of thrombosis prevention
April 13, 2018
SAN DIEGO – One expert says it’s the ability to determine the risk of recurrence with or without continuation of anticoagulant treatment.
![1]()
News
Two scoring systems helpful in diagnosing heparin-induced thrombocytopenia
April 8, 2018
SAN DIEGO – Both the 4Ts Score or the HIT Expert Probability (HEP) Score performed well in a real-world study.
![1]()
News
Few acutely ill hospitalized patients receive VTE prophylaxis
April 2, 2018
The results “imply that there is a significantly unmet need for effective VTE prophylaxis in both the inpatient and outpatient continuum of care.”
![1]()
News
Protocol helped identify hospitalized children at risk for VTE
March 30, 2018
SAN DIEGO – Children with hospital-acquired VTE tended to be more medically complex, a single-center study showed.
![1]()
News
Warfarin dose capping avoided supratherapeutic INRs in hospitalized elderly
March 30, 2018
SAN DIEGO – Limiting the initial dose of warfarin to 2.5 mg or less for hospitalized patients aged 85 years and older led to significant reductions in supratherapeutic INRs.
